Delivering A New Confidence
©2019 Ivantis, Inc. Ivantis
and Hydrus are registered
trademarks of Ivantis, Inc.
All rights reserved.
IM-0007 Rev C
For Important Safety Information and
supporting references, please see page 3.
MIGS SURGEONS
CAN'T IGNORE
THE DATA IN
THE ROOM
Reporting the most medication-free
patients and the largest IOP reduction
compared to control of any MIGS pivotal
trial at 24 months, the Hydrus® Microstent
sets a new standard for high quality
patient outcomes.
1-4,*
Delivering a new confidence.
